ESCAPE Bio is a preclinical stage biopharmaceutical company focused on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. We are passionate about making a meaningful clinical impact for patients suffering from CNS diseases and believe in a genetically defined approach to achieving this goal.
Location: United States, California, South San Francisco
Member count: 11-50
Total raised: $73M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 14.09.2020 | - | $73M | - | orbimed.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 14.09.2020 | ESCAPE Bio... | SOUTH SAN FRANCISCO, Calif.--(... | - | - | citybizlis... |
| 14.09.2020 | ESCAPE Bio... | SOUTH SAN FRANCISCO, CA, ESC... | - | - | vcnewsdail... |
| 14.09.2020 | ESCAPE Bio... | - | - | - | jnjinnovat... |
| 14.09.2020 | Escape Bi... | Escape Bio has drifted from ... | - | Jason Mast | endpts.com... |
| 14.09.2020 | ESCAPE BIO... | - | - | - | orbimed.co... |